Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An acute leukemia of ambiguous lineage in which there is a dual population of blasts with each population expressing markers of a distinct lineage (myeloid and lymphoid or B-and T-lymphocyte). (WHO, 2001) -- 2003
Biomarker and diagnostic research for bilineal acute myeloid leukemia has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
6 publications have been identified in PubMed for bilineal acute myeloid leukemia. Research spans Case Report / Case Series (33%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Zhang B (2026). [PMID: 41555968](https://pubmed.ncbi.nlm.nih.gov/41555968/). *EJHaem*. [Epidemiology / Natural History]
Huang B (2025). [PMID: 41318446](https://pubmed.ncbi.nlm.nih.gov/41318446/). *Genome medicine*. [Basic Science / Preclinical]
Nair G (2025). [PMID: 41224689](https://pubmed.ncbi.nlm.nih.gov/41224689/). *BMJ case reports*. [Review / Meta-Analysis]
Hennawi M (2024). [PMID: 38695552](https://pubmed.ncbi.nlm.nih.gov/38695552/). *Applied immunohistochemistry & molecular morphology : AIMM*. [Case Report / Case Series]
Li K (2024). [PMID: 39078014](https://pubmed.ncbi.nlm.nih.gov/39078014/). *Turkish journal of haematology : official journal of Turkish Society of Haematology*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Oct 3, 2026, 6:07 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Demina I (2024). [PMID: 38891797](https://pubmed.ncbi.nlm.nih.gov/38891797/). *International journal of molecular sciences*. [Diagnostic / Biomarker]
AI-curated news mentioning bilineal acute myeloid leukemia
Updated Aug 17, 2026
Recent research demonstrates that dimensionality reduction techniques can enhance minimal residual disease (MRD) visualization in single-sample flow cytometric analysis for acute leukemia. This advancement could improve diagnostic accuracy and treatment monitoring for patients.